Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tamoxifen retinopathy.

M I Kaiser-Kupfer, M E Lippman

    Cancer Treatment Reports
    |March 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    High-dose tamoxifen (a chemotherapy drug) can cause vision loss due to retinal and corneal toxicity in patients using it long-term. Further research is needed to understand these ocular side effects.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.

    Breast cancer research and treatment·2019
    Same author

    Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.

    Breast cancer research and treatment·2017
    Same author

    Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.

    Oncogene·2016
    Same author

    Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.

    Oncogene·2015
    Same author

    CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.

    Breast cancer research and treatment·2013
    Same author

    Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody.

    Breast cancer research and treatment·2009

    Area of Science:

    • Ophthalmology
    • Oncology
    • Pharmacology

    Background:

    • Tamoxifen is a widely used chemotherapeutic agent.
    • Previous studies have not extensively documented serious side effects.
    • Ocular toxicity is a potential concern with long-term drug use.